366 related articles for article (PubMed ID: 34520322)
1. Using PAMPs and DAMPs as adjuvants in cancer vaccines.
Sun H; Hu W; Yan Y; Zhang Z; Chen Y; Yao X; Teng L; Wang X; Chai D; Zheng J; Wang G
Hum Vaccin Immunother; 2021 Dec; 17(12):5546-5557. PubMed ID: 34520322
[TBL] [Abstract][Full Text] [Related]
2. Immunological Mechanism and Clinical Application of PAMP Adjuvants.
Yan Y; Yao D; Li X
Recent Pat Anticancer Drug Discov; 2021; 16(1):30-43. PubMed ID: 33563182
[TBL] [Abstract][Full Text] [Related]
3. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.
Ong GH; Lian BSX; Kawasaki T; Kawai T
Front Cell Infect Microbiol; 2021; 11():745016. PubMed ID: 34692565
[TBL] [Abstract][Full Text] [Related]
4. Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination.
Jounai N; Kobiyama K; Takeshita F; Ishii KJ
Front Cell Infect Microbiol; 2012; 2():168. PubMed ID: 23316484
[TBL] [Abstract][Full Text] [Related]
5. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.
Miyaji EN; Carvalho E; Oliveira ML; Raw I; Ho PL
Braz J Med Biol Res; 2011 Jun; 44(6):500-13. PubMed ID: 21584443
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination.
Ni K; Lan G; Guo N; Culbert A; Luo T; Wu T; Weichselbaum RR; Lin W
Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008911
[TBL] [Abstract][Full Text] [Related]
7. Use of adjuvants for immunotherapy.
Circelli L; Tornesello M; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2017 Aug; 13(8):1774-1777. PubMed ID: 28604160
[TBL] [Abstract][Full Text] [Related]
8. Innate signaling by mycobacterial cell wall components and relevance for development of adjuvants for subunit vaccines.
Tima HG; Huygen K; Romano M
Expert Rev Vaccines; 2016 Nov; 15(11):1409-1420. PubMed ID: 27206681
[TBL] [Abstract][Full Text] [Related]
9. Resolving adjuvant mode of action to enhance vaccine efficacy.
Turley JL; Lavelle EC
Curr Opin Immunol; 2022 Aug; 77():102229. PubMed ID: 35779364
[TBL] [Abstract][Full Text] [Related]
10. Flagellin as a vaccine adjuvant.
Cui B; Liu X; Fang Y; Zhou P; Zhang Y; Wang Y
Expert Rev Vaccines; 2018 Apr; 17(4):335-349. PubMed ID: 29580106
[TBL] [Abstract][Full Text] [Related]
11. Exploiting vita-PAMPs in vaccines.
Blander JM; Barbet G
Curr Opin Pharmacol; 2018 Aug; 41():128-136. PubMed ID: 29890457
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Vaccines for Cancer Immunotherapy.
Wang J; Mamuti M; Wang H
ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
[TBL] [Abstract][Full Text] [Related]
13. Chimeric NOD2 Mincle Agonists as Vaccine Adjuvants.
Dangerfield EM; Ishizuka S; Kodar K; Yamasaki S; Timmer MSM; Stocker BL
J Med Chem; 2024 Apr; 67(7):5373-5390. PubMed ID: 38507580
[TBL] [Abstract][Full Text] [Related]
14. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
15. Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments.
Cuzzubbo S; Mangsbo S; Nagarajan D; Habra K; Pockley AG; McArdle SEB
Front Immunol; 2020; 11():615240. PubMed ID: 33679703
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharides: Candidates of promising vaccine adjuvants.
Li P; Wang F
Drug Discov Ther; 2015 Apr; 9(2):88-93. PubMed ID: 25994059
[TBL] [Abstract][Full Text] [Related]
17. Bacterial outer membrane vesicle-based cancer nanovaccines.
Gao X; Feng Q; Wang J; Zhao X
Cancer Biol Med; 2022 Sep; 19(9):1290-300. PubMed ID: 36172794
[TBL] [Abstract][Full Text] [Related]
18. Synthetic vaccines: the role of adjuvants in immune targeting.
Jiang ZH; Koganty RR
Curr Med Chem; 2003 Aug; 10(15):1423-39. PubMed ID: 12871139
[TBL] [Abstract][Full Text] [Related]
19. Role of Damage-Associated Molecular Pattern/Cell Death Pathways in Vaccine-Induced Immunity.
Lee SM; Kim P; You J; Kim EH
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960608
[TBL] [Abstract][Full Text] [Related]
20. Cancer vaccine adjuvants--recent clinical progress and future perspectives.
Banday AH; Jeelani S; Hruby VJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):1-11. PubMed ID: 25318595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
